JPRN-UMIN000009589已完成未知
The effect of Eldecalcitol for glucocorticoid induced osteoporosis patients who are not recommended bisphosphonates therapy - The effect of Eldecalcitol for glucocorticoid induced osteoporosis patients who are not recommended bisphosphonates therapy
Department of Rheumatic Disease, Shinko Hospital0 个研究点目标入组 40 人开始时间: 2012年12月20日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with contraindication for Eldecalcitol treatments 2. Patients who are inappropriate for this study by physicians.
研究者
相似试验
已完成
不适用
The additive effect of Eldecalcitol for glucocorticoid induced osteoporosis responding poorly to Alendronate.glucocorticoid induced osteoporosisJPRN-UMIN000009586Department of Rheumatic Disease, Shinko Hospital80
已完成
不适用
Eldecalcitol for GLucocorticoid induced OsteopoRosIs versus AlfacalcidolGlucocorticoid-induced osteoporosisJPRN-UMIN000011700e-GLORIA trial Protocol Review Committee (Executive Committee)373
Unknown
不适用
Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus AlfacalcidolOsteoporosisNCT01974167e-GLORIA trial Protocol Review Committee400
进行中（未招募）
1 期
The effect of intravenous glucocorticoids on the tearfilm in eyes with thyroid-associated ophthalmopathyThyroid-associated ophthalmopathy (TAO)MedDRA version: 14.1Level: LLTClassification code 10065624Term: Graves-Basedow diseaseSystem Organ Class: 10014698 - Endocrine disordersEUCTR2012-001910-40-ATMedizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie24
进行中（未招募）
1 期
A Pilot Study of the Effect of Glucocorticoid Receptor Antagonism in Patients with Sub-Clinical Cushing's Syndrome - Glucocorticoid Receptor Antagonism in Sub-Clinical CushingsEUCTR2007-007604-15-GBSheffield Teaching Hospitals NHS Foundation Trust